Financial Security Advisor Inc. Has $966,000 Stock Holdings in Danaher Co. (NYSE:DHR)

Financial Security Advisor Inc. grew its position in shares of Danaher Co. (NYSE:DHR) by 27.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,207 shares of the conglomerate’s stock after acquiring an additional 905 shares during the quarter. Financial Security Advisor Inc.’s holdings in Danaher were worth $966,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Heck Capital Advisors LLC acquired a new position in Danaher during the 4th quarter worth approximately $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher during the 4th quarter worth approximately $31,000. Golden State Wealth Management LLC acquired a new position in Danaher during the 4th quarter worth approximately $31,000. Strategic Financial Concepts LLC acquired a new position in Danaher during the 4th quarter worth approximately $31,000. Finally, Pineridge Advisors LLC boosted its position in Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 57 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Down 1.8 %

DHR stock opened at $205.69 on Friday. The stock has a market capitalization of $147.01 billion, a price-to-earnings ratio of 38.96, a PEG ratio of 2.66 and a beta of 0.83. Danaher Co. has a fifty-two week low of $196.80 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The business’s fifty day moving average price is $225.00 and its two-hundred day moving average price is $245.50.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the company posted $2.09 EPS. On average, equities analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.32 dividend. The ex-dividend date is Friday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.62%. Danaher’s dividend payout ratio (DPR) is currently 24.24%.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is owned by corporate insiders.

Analyst Ratings Changes

DHR has been the subject of a number of recent research reports. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target for the company in a research report on Thursday, October 31st. The Goldman Sachs Group set a $250.00 price objective on Danaher in a research note on Wednesday, January 15th. Guggenheim initiated coverage on Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 price objective on the stock. Jefferies Financial Group dropped their price objective on Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th. Finally, StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Seven equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.